The only case series where the majority of cases (64%) were expected to have a higher NROA compared to XL-CGD (genetic defect identified in 84%) [11] identified very few inflammatory complications, which is likely to be more representative of p47phox defects. The gene discussed is NCF1; the disease is chronic granulomatous disease.